Aisling Capital IV Overview
- Fund Type
-
Venture
- Fund Status
-
Fully Invested
- Fund Manager
- Aisling Capital
- Size
-
- Vintage
-
2016
- Dry Powder
-
Aisling Capital IV General Information
Description
Aisling Capital IV is a 2016 vintage later-stage venture capital fund managed by Aisling Capital. The fund is located in New York, New York, and invested in the United States. The fund targeted life sciences, pharmaceuticals, and biotechnology sectors.
Contact Information
Fund Manager's Location
- 489 Fifth Avenue
- Floor 10
- New York, NY 10017
- United States
Aisling Capital IV Investments (45)
Aisling Capital IV has made a total of 45 investments. Its most recent deal was a with Wugen for . The deal was made on 16-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Wugen | 16-Dec-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Antios Therapeutics | 03-Nov-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Stratus Therapeutics | 07-Sep-2021 | Drug Discovery | Generating Revenue | |||
| Medical Knowledge Group | 15-Jul-2021 | Media and Information Services (B2B) | Profitable | |||
| Treeline Biosciences | 09-Apr-2021 | Drug Discovery | Clinical Trials - General | |||
| Antios Therapeutics | 09-Apr-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Reneo Pharmaceuticals | 16-Mar-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Monte Rosa Therapeutics | 12-Mar-2021 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Elevation Oncology | 12-Nov-2020 | Early Stage VC (Series B) | Drug Discovery | Startup | ||
| Nuvation Bio | 15-Oct-2020 | Early Stage VC (Series A) | Drug Discovery | Pre-Clinical Trials |
Aisling Capital IV Investment Strategy
Investments by Industry
Investments by Deal Type
Aisling Capital IV Limited Partners (3)
Andrew W. Mellon Foundation is one of Aisling Capital IV’s 3 limited partners. Its latest Original was on 22-Jun-2017.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Andrew W. Mellon Foundation | Current | 22-Jun-2017 | Original | ||
| Missouri Department of Transportation and Highway Patrol Employees' Retirement System | Current | 22-Jun-2017 | Original | ||
| Pennsylvania Public School Employees Retirement System | Public Pension Fund | Current | 19-Aug-2015 | Original |
Aisling Capital IV Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Aisling Capital IV Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Aisling Capital IV Benchmark (67)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Drive Capital Fund II | 31-Mar-2025 | ||||
| Thrive Capital Partners V | |||||
| 5AM Ventures V | 31-Mar-2025 | ||||
| TCV IX | 31-Mar-2025 | ||||
| Menlo Special Opportunities Fund | 31-Dec-2022 | ||||
| Battery Ventures XI Side Fund | 31-Mar-2025 | ||||
| BlueCross BlueShield Venture Partners III | |||||
| Intact Ventures I | |||||
| Accel Leaders Fund | |||||
| Aisling Capital IV | 30-Sep-2024 |
Aisling Capital IV FAQs
-
What is Aisling Capital IV?
Aisling Capital IV is a 2016 vintage later-stage venture capital fund managed by Aisling Capital.
-
Who manages Aisling Capital IV?
Aisling Capital IV is managed by Aisling Capital.
-
Where is Aisling Capital IV domiciled?
Aisling Capital IV is domiciled in United States: Delaware.
-
What is Aisling Capital IV's size?
Aisling Capital IV has a size of .
-
What type of fund is Aisling Capital IV?
The fund type of Aisling Capital IV is Venture.
-
What is the status of Aisling Capital IV?
Aisling Capital IV is fully invested.
-
What has Aisling Capital IV invested in?
Aisling Capital IV has made numerous investments in companies like Wugen, Antios Therapeutics, and Stratus Therapeutics within the Drug Discovery industry.
-
What has Aisling Capital IV invested in recently?
Aisling Capital IV's latest investment was on 16-Dec-2022 in Wugen, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
